Arcutis Biotherapeutics, Inc. Insider Trading for May 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Arcutis Biotherapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Arcutis Biotherapeutics, Inc. for May 2021.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 12 2021 | ARQT | Arcutis Biotherape ... | Frazier Life Sciences VIII, L. ... | 10% Owner | Sell | J | 0.00 | 96,574 | 0 | 0 | 96.6 K to 0 (-100.00 %) |
May 12 2021 | ARQT | Arcutis Biotherape ... | Frazier Life Sciences VIII, L. ... | 10% Owner | Buy | J | 0.00 | 96,574 | 0 | 96,574 | 0 to 96.6 K |
May 12 2021 | ARQT | Arcutis Biotherape ... | Frazier Life Sciences VIII, L. ... | 10% Owner | Sell | J | 0.00 | 2,108,558 | 0 | 8,434,232 | 10.5 M to 8.4 M (-20.00 %) |
May 11 2021 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Option Exercise | M | 1.68 | 750 | 1,260 | 133,135 | |
May 11 2021 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Sell | S | 35.00 | 750 | 26,250 | 593,773 | 594.5 K to 593.8 K (-0.13 %) |
May 11 2021 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Buy | M | 1.68 | 750 | 1,260 | 594,523 | 593.8 K to 594.5 K (+0.13 %) |
May 07 2021 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Option Exercise | M | 1.68 | 1,607 | 2,701 | 133,885 | |
May 07 2021 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Sell | S | 34.00 | 1,750 | 59,500 | 593,773 | 595.5 K to 593.8 K (-0.29 %) |
May 07 2021 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Buy | M | 1.68 | 1,607 | 2,701 | 595,523 | 593.9 K to 595.5 K (+0.27 %) |
May 05 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Option Exercise | M | 6.52 | 1,028 | 6,705 | 11,919 | |
May 05 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Option Exercise | M | 1.68 | 781 | 1,313 | 24,990 | |
May 05 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Option Exercise | M | 1.68 | 391 | 657 | 11,714 | |
May 05 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Sell | S | 35.12 | 917 | 32,209 | 210,941 | 211.9 K to 210.9 K (-0.43 %) |
May 05 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Sell | S | 34.56 | 1,283 | 44,339 | 211,858 | 213.1 K to 211.9 K (-0.60 %) |
May 05 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Buy | M | 6.52 | 1,028 | 6,705 | 213,141 | 212.1 K to 213.1 K (+0.48 %) |
May 05 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Buy | M | 1.68 | 781 | 1,313 | 212,113 | 211.3 K to 212.1 K (+0.37 %) |
May 05 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Buy | M | 1.68 | 391 | 657 | 211,332 | 210.9 K to 211.3 K (+0.19 %) |
May 04 2021 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Sell | S | 35.00 | 1,500 | 52,500 | 593,916 | 595.4 K to 593.9 K (-0.25 %) |